Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Entera Bio (NASDAQ:ENTX) through any online brokerage.
Other companies in Entera Bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Entera Bio has a consensus price target of $9.75.
The stock price for Entera Bio (NASDAQ: ENTX) is $3.05 last updated October 20, 2026 at 6:38 PM EDT.
There are no upcoming dividends for Entera Bio.
Entera Bio does not have any upcoming earnings scheduled.
There is no upcoming split for Entera Bio.
Entera Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.